Arcutis Biotherapeutics's total assets for Q4 2024 were $348.89M, a decrease of -20.23% from the previous quarter. ARQT total liabilities were $191.35M for the fiscal quarter, a -31.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.